Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Pragmatic, Open-Label Trial To Evaluate The Effect Of Three Months Of High Dose Rifapentine Plus Isoniazid Administered As A Single Round Or Given Annually In HIV-Positive Individuals

NCT02980016 is registered in ClinicalTrials.gov with The Aurum Institute NPC as lead sponsor.

NCT NCT02980016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02980016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Pragmatic, Open-Label Trial To Evaluate The Effect Of Three Months Of High Dose Rifapentine Plus Isoniazid Administered As A Single Round Or Given Annually In HIV-Positive Individuals
Lead sponsor
The Aurum Institute NPC
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2016
Completion date
October 18, 2019
Enrollment
4,027 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, tuberculosis